A&W Canada’s Burgers to Beat MS Day is returning for its 17th year to raise funds for MS Canada and its efforts to support ...

MS may increase the risk of Alzheimer's disease, possibly due to changes in the activity of immune T-cells, a new genetic ...

Columnist Desiree Lama describes how her pill box became essential as her life with multiple sclerosis meant more and more ...

Fumarate therapies are equally effective among Black, Hispanic, Asian, and white people with relapsing forms of MS, a real-world study shows.

Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Columnist Ahna Crum, who's a practitioner in functional medicine, questioned herself when she had an unexpected MS relapse.

Regular exercise that follows established guidelines for physical activity in MS lead to clinically meaningful improvements ...

A six-week music-based intervention may reduce psychosocial fatigue and heat pain sensitivity in people with multiple ...

An international Phase 2 trial will test BMS-986368 as a potentially new oral therapy for managing multiple sclerosis-related ...

Researchers have developed a blood test to predict MS onset by measuring EBV antibody levels, potentially allowing early diagnosis and care.